This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation.

Verwandte Artikel

Leading Pharmaceutical Innovation Gassmann, Oliver, Reepmeyer, Gerrit, Zedtwitz, Max Von, Schuhmacher, Alexander

85,59 €*

Weitere Produkte vom selben Autor

Geschäftsmodelle entwickeln Gassmann, Oliver, Frankenberger, Karolin, Choudury, Michaela

44,99 €*
Der St. Galler Business Model Navigator Gassmann, Oliver, Frankenberger, Karolin, Choudury, Michaela

49,99 €*
Führung und Organisation pharmazeutischer Innovation Gassmann, Oliver, Schuhmacher, Alexander, Zedtwitz, Max Von, Reepmeyer, Gerrit

44,99 €*
Digitale Transformation gestalten Gassmann, Oliver, Sutter, Oliver

52,70 €*